[3-[(3-chloro-2-hydroxypropyl)amino]-5-nitrophenyl]-piperidin-1-ylmethanone
C15H20ClN3O4 — CID 168638094
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-[(3-chloro-2-hydroxypropyl)amino]-5-nitrophenyl]-piperidin-1-ylmethanone
[3-[(3-chloro-2-hydroxypropyl)amino]-5-nitrophenyl]-piperidin-1-ylmethanone (PubChem CID 168638094) has the molecular formula C15H20ClN3O4 and a molecular weight of 341.80 g/mol. Its IUPAC name is [3-[(3-chloro-2-hydroxypropyl)amino]-5-nitrophenyl]-piperidin-1-ylmethanone.
Molecular Properties
| Compound Name | [3-[(3-chloro-2-hydroxypropyl)amino]-5-nitrophenyl]-piperidin-1-ylmethanone |
|---|---|
| PubChem CID | 168638094 |
| Molecular Formula | C15H20ClN3O4 |
| Molecular Weight | 341.80 g/mol |
| Exact Mass | 341.11 |
| IUPAC Name | [3-[(3-chloro-2-hydroxypropyl)amino]-5-nitrophenyl]-piperidin-1-ylmethanone |
| SMILES | O=C(c1cc(NCC(O)CCl)cc([N+](=O)[O-])c1)N1CCCCC1 |
| InChI | InChI=1S/C15H20ClN3O4/c16-9-14(20)10-17-12-6-11(7-13(8-12)19(22)23)15(21)18-4-2-1-3-5-18/h6-8,14,17,20H,1-5,9-10H2 |
| InChIKey | ZTDBLUMPQRFMSH-UHFFFAOYSA-N |
| XLogP | 2.23 |
| TPSA | 95.71 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 341.80 |
| LogP ≤ 5 | 2.23 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168638094 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.